Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Ovarian Cancer

Mum's warning after 'menopause symptoms' turn out to be 'silent killer' ovarian cancer

A mum-of-two has warned women of the symptoms of a 'silent killer' after her irregular periods led her to believe she was going through the menopause - but it turned out to be ovarian cancer

Daily Mirror

Teacher thought she was starting menopause before life-changing ovarian cancer diagnosis

The disease is known as the 'silent killer'

Wales Online

Rebecca Balding death: Charmed and Soap actor dies from ovarian cancer, aged 73

News was confirmed by Balding’s husband James Conway

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Newcastle teacher thought she was going through the menopause - but it was 'silent killer' ovarian cancer

Emma Durkin was diagnosed with the disease after medics removed an abscess from her ovary

Chronicle Live

Rebecca Balding dead: Charmed and Soap star dies after secret cancer battle aged 73

Charmed and Soap star Rebecca Balding has passed away after secret battle with ovarian cancer at the age of 73

Daily Mirror

Margo Jefferson feels ghosts around her. The Chicago-born writer of ‘Negroland’ spends a day with us visiting some of them.

CHICAGO — Margo Jefferson, who has worked a half-century as one of the more formidable and composed critics of American culture, watched the city unwind from the back seat of an SUV. We moved slowly through traffic, maneuvering from the Loop to Wicker Park. She doesn’t get back here often…

Chicago Tribune

Cyclacel To Test Higher Doses Of Fadraciclib In Solid Tumor Patients

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) is adding two dose levels in a protocol amendment to test higher doses of oral fadraciclib before determining the recommended Phase 2 dose anticipated in 2H of 2022, citing the absence of dose-limiting toxicities. Fifteen patients with advanced solid tumors and lymphomas were treated with oral fadraciclib at all…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Corcept Therapeutics Commences Late-Stage Ovarian Cancer Study

Corcept Therapeutics (NASDAQ: CORT) has initiated pivotal Phase 3 clinical trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer.

Benzinga

Cancer survivors facing crippling anxiety and isolation after treatment

Cassie Burns battled to return to normal life after being given the all-clear with concerns about her physical changes and fears her ovarian cancer would return

Daily Mirror

CLSN: OVATION 2 Study 85% Enrolled…

By David Bautz, PhD NASDAQ:CLSN READ THE FULL CLSN RESEARCH REPORT

Benzinga

Janey Godley feels 'positive' despite being kept in hospital for blood transfusion

Janey was diagnosed with ovarian cancer at the end of last year and has been regularly sharing updates on social media regarding her condition. In the latest post, she says that she has been told to stay in hospital for a blood transfusion

Edinburgh Live

Glasgow comedian Janey Godley back in hospital during cancer battle

The Scottish comedian has returned to the hospital for a blood tranfusion, as she battles ovarian cancer, but is keeping her followers up to date with her journey.

Glasgow Live

Janey Godley at Glasgow restaurant in good spirits with comic pal Jason Manford

The Scottish comedian was looking cheerful as she met up with fellow comic pal Jason Manford at her favourite Glaswegian eater, Eusebi Deli, as she battles ovarian cancer.

Glasgow Live

SELLAS Life Sciences's Galinpepimut/Opdivo Combo Shows Increased Survival In Mesothelioma Patients

SELLAS Life Sciences Group Inc (NASDAQ:SLS) announced updated data from a Phase 1 clinical trial of galinpepimut-S (GPS), combined with Bristol-Myers Squibb Co's (NYSE:BMY) nivolumab (Opdivo) in with malignant pleural mesothelioma (MPM). The trial included patients who were either refractory or relapsed after at least one line of the standard of care therapy. Data from…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Sajid Javid criticises changes to NHS pages removing word ‘women’

Health secretary says ‘I don’t think it’s right’ after reported amendments to advice pages about ovarian cancer

Evening Standard

Sajid Javid: NHS ovarian cancer guidance should use word ‘women’

The Health Secretary said ‘common sense and the right language’ should be used

The Independent UK

Sajid Javid disagrees with NHS ‘removing woman’ from ovarian cancer guidance

Health secretary says he will looking into the wording

The Independent UK

Health Secretary ‘looking into’ ovarian cancer wording on NHS website

Sajid Javid said ‘common sense and the right language’ should be used.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

RBC Says Verastem Interim Analysis In Ovarian Cancer Reinforces Enthusiasm

With the anticipation of a 2Q program update, Verastem Oncology (NASDAQ:VSTM) announced that its interim analysis findings for the RAMP 201 program for recurrent low-grade serous ovarian cancer (LGSOC) continue evaluation in both monotherapy and combination regimens. With incremental updates from ASCO, reiterated KOL enthusiasm, and more updates are upcoming in 2022 on a…

Irish Mirror

Irish woman, 22, diagnosed with stage three breast cancer after finding small lump

Lauren Barrett said she received her cancer diagnosis at the same time she was told she is a carrier of the BRCA1 gene mutation, which is linked to both breast and ovarian cancer

Benzinga

Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In Pretreated Patients

SELLAS Life Sciences Group Inc (NASDAQ:SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian cancer. The trial evaluated SELLAS' peptide immunotherapeutic combined with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab). Data from 15 patients enrolled in the study has been preliminarily analyzed. Final…

Benzinga

What's Going On With ImmunoGen Shares Today?

ImmunoGen, Inc. (NASDAQ: IMGN) shares are trading flat at $3.57 after the company's Biologics License Application to treat ovarian cancer was accepted by the FDA with priority review.

Daily Mirror

Ovarian cancer: Four key symptoms that 90 per cent of women are unaware of

Stomach pain, bloating and fatigue are just some of the things to watch out for, especially in those aged 50 and above. Here we detail what you should do if you think you have any symptoms of ovarian cancer.

Daily Record

Couple 'traumatised' after being diagnosed with cancer within months of each other

After Paul Boothby, 69, was told he has stage three bowel cancer in August 2021, his partner Diane Boothby, 63, decided to pay for a private scan to get to the root of her symptoms.

Wales Online

Healthy mum chooses to have breasts removed so she can see her sons grow up

Ruth Cookson has a gene mutation that made her more susceptible to breast and ovarian cancer

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.